Biopsy Needle Market to Surpass $3.9 Billion by 2032 at 7.8% CAGR The Biopsy Needle market is witnessing significant expansion, with global valuation reaching USD 2.1 billion in 2023, rising to USD 2.3 billion in 2024, reflecting a 9.5% year-over-year growth. Increasing cancer prevalence, which accounted for over 19.3 million new cases globally in 2022, is a major growth driver. The market is projected to reach USD 3.9 billion by 2032, growing at a CAGR of 7.8% during 2024–2032. Read Full Research Study: https://marketintelo.com/report/biopsy-needle-market